Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Captor Therapeutics SA logo — Captor Therapeutics aims to treat cancer, infections, and di...

Captor Therapeutics SA

Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the difficult-to-drug proteome.

Founded 2017 Poland Poland 79 employees IPO Total: $68.50M Biopharma, Biotechnology +1

General Information

Company Name Captor Therapeutics SA
Founded Year 2017
Location Poland Poland
Employees 79
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage IPO
Business Model B2B, B2B2C
Revenue Model Licensing, Performance Based, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Captor Therapeutics SA. To contact Captor Therapeutics SA, visit captortherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Captor Therapeutics SA compare?

A PDF of Captor Therapeutics SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Captor Therapeutics SA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Captor Therapeutics SA

Captor Therapeutics SA is a pioneering company in the Biopharma, Biotechnology, and Pharmaceutical industries, headquartered in Poland. Founded in 2017, the company is publicly listed on the Warsaw Stock Exchange under the ticker WSE:CTX.

Captor Therapeutics focuses on advancing drug discovery and development through targeted protein degradation to address the "undruggable" proteome. Its mission is to significantly impact the lives of patients suffering from cancer, autoimmunity, and neurodegenerative diseases by developing innovative therapeutics. The company prides itself on groundbreaking technology capable of producing new drug candidates aimed at curing conditions traditionally challenging to treat.

Recently, Captor Therapeutics secured a substantial PLN66.00M Post IPO Equity investment on 01 March 2026, with participation from the EIC Fund, underscoring investor confidence in its potential to transform patient outcomes and address critical medical challenges.

Business keywords: Targeted Protein Degradation, Drug Discovery, Cancer Treatment, Autoimmune Disease Treatment, Neurodegenerative Disease Treatment, Proteome Targeting, Biotechnology Innovation, Pharmaceutical Development, Undruggable Proteome, Pharmacokinetics and Pharmacodynamics, Intracellular Protein Degradation, Small Molecule Therapeutics, European Union Co-financed Projects

Services & Products

Drug discovery using Targeted Protein Degradation (TPD) technology
Development of therapeutics for cancer and autoimmune diseases
Structure-guided optimization of lead compounds

Target Customers

Healthcare providers Pharmaceutical companies Patients with severe conditions like cancer and autoimmune diseases Research institutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity PLN66.00M 1
EIC Fund
01 Mar 2026
Early VC $2.50M 1
European Innovation Council
European Innovation Council
01 Oct 2024
IPO Undisclosed -
01 Apr 2021

Captor Therapeutics SA Alternatives & Competitors

View All Alternatives
Captor Therapeutics SA vs
Avilar Therapeutics
Avilar Therapeutics United States

Pioneering the discovery and development of extracellular protein degraders.

Seed
25 employees
Biotechnology, Pharmaceutical
Compare Captor Therapeutics SA vs Avilar Therapeutics
Captor Therapeutics SA vs
Cullgen Inc.
Cullgen Inc. United States

Powering protein degradation for tomorrow's medicines

Acquired
27 employees
Biotechnology, Pharmaceutical
Compare Captor Therapeutics SA vs Cullgen Inc.
Captor Therapeutics SA vs
Frontier Medicines
Frontier Medicines United States

Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transform patients...

Series C
81 employees
Biopharma, Biotechnology
Also compare with: Captor Therapeutics SA vs Amphista Therapeutics Limited Amphista Therapeutics Limited View all alternatives

FAQ About Captor Therapeutics SA

Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the difficult-to-drug proteome.
Captor Therapeutics SA was founded in 2017.
Captor Therapeutics SA is headquartered in Poland.
Captor Therapeutics SA operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on Targeted Protein Degradation, Drug Discovery, Cancer Treatment and Autoimmune Disease Treatment. Its customers include Healthcare providers, Pharmaceutical companies and Patients with severe conditions like cancer and autoimmune diseases.
Captor Therapeutics SA has a B2B and B2B2C business model. Its revenue comes from Licensing, Performance Based and Product Sales.
Captor Therapeutics SA has approximately 79 employees.
Captor Therapeutics SA has completed 3 funding rounds, raising a total of $68.50M. The latest funding stage is IPO.
Captor Therapeutics SA offers: Drug discovery using Targeted Protein Degradation (TPD) technology, Development of therapeutics for cancer and autoimmune diseases, Structure-guided optimization of lead compounds.
Top alternatives and competitors to Captor Therapeutics SA include Avilar Therapeutics, Cullgen Inc., Frontier Medicines, Amphista Therapeutics Limited, Xanthus Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Captor Therapeutics SA and Avilar Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Captor Therapeutics SA, https://bouncewatch.com/company/captor-therapeutics, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes